Antagonizing Sec62 function in intracellular Ca<sup>2+</sup> homeostasis represents a novel therapeutic strategy for head and neck cancer.

Antagonizing Sec62 function in intracellular Ca²⁺ homeostasis represents a novel therapeutic strategy for head and neck cancer.

Körner, Sandrina; Pick, Tillman; Bochen, Florian; Wemmert, Silke; Körbel, Christina; Menger, Michael D; Cavalié, Adolfo; Kühn, Jan-Philipp; Schick, Bernhard; Linxweiler, Maximilian.

Körner S; Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center, Homburg, Germany.
Pick T; Experimental and Clinical Pharmacology and Toxicology, Pre-Clinical Center for Molecular Signalling (PSMZ), Saarland University, Homburg, Germany.
Bochen F; Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center, Homburg, Germany.
Wemmert S; Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center, Homburg, Germany.
Körbel C; Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
Menger MD; Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
Cavalié A; Experimental and Clinical Pharmacology and Toxicology, Pre-Clinical Center for Molecular Signalling (PSMZ), Saarland University, Homburg, Germany.
Kühn JP; Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center, Homburg, Germany.
Schick B; Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center, Homburg, Germany.
Linxweiler M; Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center, Homburg, Germany.